- Tricuspid valve repair procedures, which restore the function of the heart’s tricuspid valve without the need for replacement, are becoming increasingly vital in the management of valvular heart diseases. These procedures are preferred for their ability to preserve native valve anatomy, reduce complications, and improve long-term patient outcomes, especially in both aging populations and individuals with functional tricuspid regurgitation
- The growing demand for tricuspid valve repair is primarily fueled by the increasing prevalence of cardiovascular diseases, rising awareness about early intervention, and advancements in minimally invasive and transcatheter technologies, which offer safer alternatives to open-heart surgery
- North America dominated the tricuspid valve repair market with the largest revenue share of 41.6% in 2024, driven by the region’s strong healthcare infrastructure, early adoption of innovative cardiac therapies, high prevalence of cardiac disorders, and the presence of leading device manufacturers. The U.S. particularly experienced significant uptake in tricuspid valve repair procedures, supported by favorable reimbursement policies and growing clinical evidence supporting transcatheter repair techniques
- Asia-Pacific is projected to be the fastest-growing region in the tricuspid valve repair market during the forecast period. Growth is supported by increasing healthcare investments, rising awareness about structural heart disease, expanding geriatric population, and the introduction of advanced cardiac intervention centers across emerging economies such as China and India
- The tricuspid valve regurgitation segment dominated the tricuspid valve repair market with a market revenue share of 64.7% in 2024, primarily due to its higher prevalence globally, especially among the elderly population and patients with left-sided heart disease or pulmonary hypertension. The availability of transcatheter and surgical repair solutions has further strengthened the market for regurgitation management
